coronavirus vaccine

Race For COVID-19 Vaccine

May 22, 2020
A volunteer is injected with either an experimental COVID-19 vaccine or a comparison shot as part of the first human trials in the U.K. to test a potential vaccine.
University of Oxford via AP

This episode originally aired on May 14, 2020.

The coronavirus pandemic wages on, and scientists and public health experts say the only way for it to come to an end is to develop, produce and distribute a vaccine as soon as possible.

As countries around the world scramble for a potential vaccine, with over 100 currently in development, there’s no clear indication of how soon one will be ready, let alone how it will be mass-produced for the world at large.

COVID-19 And Immunity

May 14, 2020
women researcher working on COVID-19 test
Ohio State University Wexner Medical Center

This episode originally aired on May 8, 2020.

By early May, more than 270,000 people have died around the world from the disease attributed to the new coronavirus.

First identified in Wuhan, China in December, the virus has infected nearly four million worldwide, including well over a million in the U.S., which now lays claim to one in every four deaths.

Race For COVID-19 Vaccine

May 14, 2020
A volunteer is injected with either an experimental COVID-19 vaccine or a comparison shot as part of the first human trials in the U.K. to test a potential vaccine.
University of Oxford via AP

The coronavirus pandemic wages on, and scientists and public health experts say the only way for it to come to an end is to develop, produce and distribute a vaccine as soon as possible.

As countries around the world scramble for a potential vaccine, with over 100 currently in development, there’s no clear indication of how soon one will be ready, let alone how it will be mass-produced for the world at large.

Most health experts agree that the need for a vaccine to prevent COVID-19 is clear.

"To return to a semblance of previous normality, the development of SARS-CoV-2 vaccines is an absolute necessity" is how a perspective in Science magazine puts it.

The Race For A Coronavirus Vaccine

May 8, 2020
women researcher working on COVID-19 test
Ohio State University Wexner Medical Center

By early May, more than 270,000 people have died around the world from the disease attributed to the new coronavirus.

First identified in Wuhan, China in December, the virus has infected nearly four million worldwide, including well over a million in the U.S., which now lays claim to one in every four deaths.

Cincinnati Children's is among four U.S. sites participating in a global clinical trial for a possible COVID-19 vaccine.

There's a chance that hundreds of millions of doses of a potential COVID-19 vaccine could be available by early next year, Dr. Anthony Fauci, a key member of the White House coronavirus task force, said Thursday, even though the federal government has not approved a vaccine against the virus.

Two of the world's largest vaccine manufacturers are joining forces to develop a new vaccine to prevent COVID-19.

Usually, the pharmaceutical behemoths GlaxoSmithKline and Sanofi are competitors, but in a conference call with reporters, GSK CEO Emma Walmsley said the coronavirus pandemic represented "an unprecedented global health threat," and, therefore, required new ways of doing business.